MRD Monitoring in Acute Lymphoblastic Leukemia
0 Pogledi
• 06/15/23
0
0
Ugraditi
administrator
Pretplatnici
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari